Most Active Stories
- What Frank Tavares, the ‘Voice of NPR,’ is Doing Today
- Chattanooga Native Bill Dedman Co-Authors ‘Empty Mansions’ Bestseller
- Local Infant Mortality Rates Decrease, But African-Americans Still Disproportionately Affected
- Ask the Doc: Should I Eat Backwards?
- Kentucky Southern Baptists Draw Crowds With Gun Giveaways
Novartis Loses Patent Battle In India
Originally published on Fri April 5, 2013 8:50 am
STEVE INSKEEP, HOST:
NPR's business news starts with a patent ruling that may affect millions.
(SOUNDBITE OF MUSIC)
INSKEEP: The ruling comes from the supreme court of India, a country with a population somewhere north of a billion. The Indian supreme court rejected patent rights claimed by the pharmaceutical giant Novartis. This ruling opens the door for Indian drug makers to produce generic versions of Novartis' lifesaving cancer drugs and will make the medicine more affordable for people in developing nations. Transcript provided by NPR, Copyright NPR.